Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Hypertension. 2016 May 16;68(1):175–184. doi: 10.1161/HYPERTENSIONAHA.115.06794

Table 1.

Baseline and left ventricular function parameters

Measures Sham (n = 10) HF (n = 10) Sham+RDN (n = 12) HF+RDN (n = 12)
Body weight (g) 408 ± 18 452 ± 26* 386 ± 10 426 ± 21
Heart weight (g) 1.3 ± 0.2 2.2 ± 0.4* 1.2 ± 0.2 2.0 ± 0.2*
Heart weight/Body weight ×1000 0.32 ± 0.05 0.49 ± 0.08* 0.31 ± 0.05 0.47 ± 0.04*
Infarct size (% of epicardial LV) 0 36 ± 6* 0 35 ± 6*
LVEDP (mmHg) 1 ± 1 25 ± 4* 1 ± 1 12 ± 3*
+dP/dt (mmHg/S) 6899 ± 329 5016 ± 378* 6856 ± 274 5366 ± 298*
−dP/dt (mmHg/S) −5749 ± 328 −3895 ± 277* −6023 ± 314 −4115 ± 169*
Plasma angiotensin II (pg/ml) 68 ± 12 175 ± 31* 53 ± 8 95 ± 12*
Plasma aldosterone (pg/ml) 1647 ± 117 2254 ± 74* 1753 ± 91 2017 ± 29*

Data are means ± SE.

*

P < 0.05 compared to sham;

P < 0.05 compared to the group without denervation. LV: left ventricle; LVEDP, left ventricular end-diastolic pressure.